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Abstract
Introduction
Non-medical prescribing was introduced into the United Kingdom (UK) to improve patient
care, through extending healthcare professionals’ roles. More recent government health
service policy focuses on the increased demand and the need for efficiency. This systematic
policy review aimed to describe any changes in government policy position and the role that
non-medical prescribing plays in healthcare provision.
Method
The systematic policy review included policy and consultation documents that describe
independent non-medical prescribing. A pre-defined protocol was registered with PROS-
PERO (CRD42015019786). Professional body websites, other relevant websites and the
following databases were searched to identify relevant documents: HMIC, Lexis Nexis, UK
Government Web Archive, UKOP, UK Parliamentary Papers and Web of Science. Docu-
ments published between 2006 and February 2018 were included.
Results and discussion
Following exclusions, 45 documents were selected for review; 23 relating to policy or strat-
egy and 22 to consultations. Of the former, 13/23 were published 2006–2010 and the
remainder since 2013. Two main themes were identified: chronological aspects and health-
care provision. In the former, a publication gap for policy documents resulted from a change
in government and associated major healthcare service reorganisation. In the later, the role
of non-medical prescribing was found to have evolved to support efficient service delivery,
and cost reduction. For many professions, prescribing appears embedded into practice;
however, the pharmacy profession continues to produce policy documents, suggesting that
prescribing is not yet perceived as normal practice.
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Conclusion
Prescribing appears to be more easily adopted into practice where it can form part of the
overall care of the patient. Where new roles are required to be established, then prescribing
takes longer to be universally adopted. While this review concerns policy and practice in the
UK, the aspect of role adoption has wider potential implications.
Introduction
Nurse prescribing was introduced in the United States of America in the 1960’s with gradual
introduction into other countries since then [1]. In 2011 Kroezen et al [1] reviewed the nurse
prescribing literature, identifying seven countries (Australia, Canada, Ireland, New Zealand,
Sweden, United Kingdom, and United States of America) that had implemented nurse pre-
scribing, with a further three countries where it was under consideration. They established
that nurse prescribing was often subjected to a closed formulary or limited by the medical con-
ditions treated, remaining subordinate to medical jurisdiction, with the United Kingdom
(UK) and Ireland notable exceptions. Kroezen et al also commented that developments with
regard to nurse prescribing were slow overall, apart from in the UK. Since that paper, the UK
has pioneered the expansion of prescribing to other non-medical professions, providing a
healthcare delivery model that could be utilised by other countries.
Traditionally, prescribing of human medicines had been perceived as a medical role, with
only medical professionals and dentists having full prescribing rights in the UK. Two seminal
reports challenged this view; the Cumberlege report [2] which paved the way for limited pre-
scribing by health visitors and district nurses, and the Crown report [3], which recommended
extending prescribing rights for the benefit of patients and to utilise the skills of healthcare
professionals. The main UK healthcare provider, within which prescribers practice, is the
National Health Service (NHS); established in 1948 to provide comprehensive healthcare to
all, free at the point of delivery [4]. The UK also has a parallel smaller privately funded health-
care sector. Healthcare policy is directed by the UK government, reflecting the principles of
the governing party at the time. Since 1948, this has been one of two main political parties
(Labour, Conservative), apart from 2010–2015 when a Conservative and Liberal Democrat
coalition was in power. As a general principle, Conservative governments tend to support free
markets and expansion of the private sector, whereas Labour governments support the NHS
over the private sector. Rising costs and changes in healthcare practice have led to numerous
reforms since the NHS was founded but, irrespective of the political stance, the founding prin-
ciples remain [4, 5].
In 2000 the governing Labour Party published a White Paper ‘The NHS Plan’, which
described the government’s intention to modernise healthcare services, breaking down the tra-
ditional demarcations between professions and introducing new ways of working to increase
healthcare capacity, shorten waiting times, and thus improve the patient experience [6]. Nurse
prescribing was highlighted as one of the 10 key roles defined by the Chief Nursing Officer
and the White Paper also included broad reference to ‘therapists’ (a generic term covering the
professions allied to health) extending their roles, with prescribing included within this [6]. To
support these sweeping changes to traditional practice the government established the Mod-
ernisation Agency, tasked with supporting service redesign at a local level [7], and launched a
consultation on extending nurse prescribing [8]. This was followed in 2002 by a consultation
on the introduction of supplementary prescribing for nurses and pharmacists [9], with
approval granted later that year [10].
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Supplementary prescribing is described as a voluntary partnership between the supplemen-
tary prescriber, the doctor looking after the patient, and the patient. The supplementary pre-
scriber is then responsible for managing and prescribing the condition(s) and medication(s)
listed in an agreed clinical management plan [11] but is unable to prescribe any other medica-
tion. The first supplementary nurse prescribers qualified in 2003, with pharmacists following in
2004. It quickly became apparent that supplementary prescribing, whilst ideal for complex and
long-term conditions, had significant limitations with regard to acute care, hampering the gov-
ernment’s desire to enhance patient care through expanding nurse and pharmacist roles and
hence improving access to medication. This was articulated clearly in the consultation docu-
ments launched in 2005 to investigate expansion into independent prescribing [12, 13]. Unlike
supplementary prescribers, independent prescribers are accountable for the care of the patient,
including examination and prescribing; Table 1 gives an overview comparing supplementary
and independent prescribing. In addition, the British National Formulary provides an overview
of independent non-medical prescribing, including the restrictions that the various professions
must abide by (https://bnf.nice.org.uk/guidance/) [14]. All non-medical prescribers are required
to complete a certified training course, be registered with their professional regulator, and to
only prescribe within their professional expertise and competence.
Legislation to implement independent prescribing by nurses and pharmacists was enacted
in 2006 [15], and since that time independent prescribing rights have been gradually extended
to a range of healthcare professionals, most recently paramedics [16]. Although non-medical
prescribing (NMP) is the umbrella term used to cover all prescribing by professions other than
doctors, in this paper it refers to independent non-medical prescribing only.
This paper refers to the activities and qualifications of non-medical professionals in the UK.
As these may vary internationally, a brief resume of the UK position is given in Table 2. Pre-
scribing forms part of advanced clinical practice, a loose definition that Health Education
England describes as involving making complex decisions at a high level of autonomy and
encompassing four components: clinical expertise, leadership, education, and research [17].
The initial focus of government policy with regard to NMP was the desire to improve patient
access to medicines. However, more recent documents from NHS England have focused on the
increased demand for services and the need to drive efficiency so that maximum benefit can be
obtained from the limited NHS budget [18, 19]. The role of NMP has been less apparent in
these later documents, and it is unclear if this reflects a change in government policy.
The aim was to conduct a systematic policy review investigating changes in UK Govern-
ment policy position with regard to NMP, since the introduction of independent prescribing
Table 1. Comparison of independent and supplementary prescribing.
Prescriber type
Independent Supplementary
Accountable for
care
p
X
Assess the patient
p
If required as part of the clinical management plan
Diagnose/confirm
diagnosis
p
X
Plan clinical
management
p
X
Prescribe
p p
Range of
medication
Any permitted by profession
relevant legislation
Any medication or class of medication listed in the agreed
clinical management plan and permitted by profession
relevant legislation
https://doi.org/10.1371/journal.pone.0214630.t001
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for nurses and pharmacists. The review also aimed to determine the current role of indepen-
dent NMP in the delivery of healthcare in the NHS, providing a snapshot of a dynamic
situation.
Table 2. Brief resume of non-medical professions.
Profession Initial qualification Regulator Medically
qualified
Core activities Advanced practice examples Further details on scope of
practice available from:
Diagnostic
radiographer
BSc HCPC No Conduct imaging tests on
patients using ionising and
non-ionising radiation.
Use contrast agents or
other medication where
necessary for investigations
Interpretation and reporting
on images
Ultrasound guided biopsies
Society of Radiographers:
https://www.sor.org
Nurse BSc NMC No Provide care for patients,
assessing needs and
delivering treatment plans
Work autonomously to
manage a patient case load in a
specialist area e.g. pain
management
Run nurse-led minor injury
clinics
Royal College of Nursing:
https://www.rcn.org.uk
Optometrist BSc GOC No Test sight and examine
eyes. Prescribe lenses.
Detect ocular disease and
abnormalities.
Diagnose, assess and manage
(including prescribing)
ophthalmic conditions–for
example glaucoma
The College of
Optometrists: https://www.
college-optometrists.org
Paramedic Diploma,
foundation degree,
BSc, apprenticeship
HCPC No Assess, treat, stabilise and
transfer patient to
appropriate care centre
Diagnose and treat patients.
Work in an urgent care centre,
or GP practice to assess and
treat patients
College of Paramedics:
https://www.
collegeofparamedics.co.uk
Pharmacist MPharm GPhC No Supply medicines to
patients, ensuring that they
are appropriate for the
patient and of suitable
quality.
Provide medicines related
advice
Work autonomously
managing a patient case load
in a specialist area e.g. renal
failure, chronic pain
Work in Emergency
Departments to independently
manage and treat patients.
General Pharmaceutical
Council: https://www.
pharmacyregulation.org
Royal Pharmaceutical
Society: https://www.
rpharms.com
Physicians
associate
Life sciences degree No regulator
Voluntary
register held by
Faculty of
Physician
Associates
No Work alongside medical
staff to care and treat
patients
(the nearest USA equivalent
role is physician’s assistant.)
Not applicable Faculty of Physician
Associates: https://www.
fparcp.co.uk
Physiotherapist BSc or MSc HCPC No Use various techniques to
enable patients to improve
movement and function
and manage pain.
Work independently to
manage a patient caseload in a
specialist area e.g. back pain or
respiratory failure
Utilise techniques such as
acupuncture, steroid injections
or botulinum toxin injections
Chartered Society of
Physiotherapy: https://www.
csp.org.uk
Podiatrist BSc HCPC No Diagnose and treat
common foot problems
Conduct podiatric surgery
Specialise in areas e.g. diabetes
care or sports medicine;
utilising techniques such as
acupuncture and steroid
injections
The College of Podiatry:
https://cop.org.uk
Therapeutic
radiographer
BSc HCPC No Use radiotherapy to treat
cancer patients.
Plan radiotherapy treatment
Independently manage and
treat patients throughout the
course of their radiotherapy
Society of Radiographers:
https://www.sor.org
BSc–Bachelor of Science, MPharm–Master of Pharmacy, MSc–Master of Science, GOC–General Optical Council, GPhC–General Pharmaceutical Council, HCPC–
Health and Care Professions Council, NMC–Nursing and Midwifery Council
https://doi.org/10.1371/journal.pone.0214630.t002
Non-medical prescribing in the United Kingdom National Health Service: Policy review
PLOS ONE | https://doi.org/10.1371/journal.pone.0214630 July 29, 2019 4 / 29
Method
Protocol and registration
A systematic policy review was conducted to explore the evolution of government policy con-
cerning independent NMP in the UK. To ensure transparency and enhance rigour a prede-
fined protocol was developed in line with the PRISMA-P statement [20] and registered with
PROSPERO (CRD42015019786) (S1 Protocol). The results are reported following the
PRISMA statement (S1 Appendix) [21].
Eligibility criteria
Documents describing policy concerning independent NMP in the UK were included. These
included White and Green Papers, policy statements, consultation documents and reports.
Documents published since 2006 were included, as the legislation permitting nurse and phar-
macist independent prescribing was enacted in that year [15].
Information sources
Advice was taken regarding appropriate electronic databases and websites to search (listed in
Table 3) and to aid development of search strategies. Broad search terms (e.g. prescribing,
non-medical) were used to capture as wide a range of documents as possible. Boolean opera-
tors and truncation were used if the database supported them. Iterative and ‘snowball’ search
techniques were employed [22], with the primary searches complete to the end of February
2018, and secondary searches conducted as necessary (S2 Appendix). Documents obtained
were mapped to identify gaps (for example, documents relating to the consultation process or
profession specific policy documents) enabling targeted secondary searches to be conducted.
Relevant citations in the reviewed documents were also obtained and personal files searched
[22]. Full texts of the selected documents were screened to remove those that did not meet the
eligibility criteria.
Policy document selection
Two reviewers (EGC and TN) independently conducted each stage, resolving differences by
discussion, with a third reviewer (AR) available if required for mediation [23]. Numbers
excluded were recorded [21, 23].
Table 3. Databases and websites searched.
Databases and websites Professional body websites
Google Scholar Chartered Society of Physiotherapists
HMIC—Ovid College of Optometrists
Lexis Nexis College of Paramedics
UK Government Web Archive General Optical Council
UKOP (UK Official Publications) General Pharmaceutical Council
UK Parliamentary Papers—ProQuest Health and Care Professions Council
Web of Science Institute of Radiology
www.gov.uk Nursing and Midwifery Council
www.health-ni.gov.uk Royal College of Nursing
www.publications.scot.nhs.uk Royal Pharmaceutical Society
www.scot.nhs.uk The Association of Ambulance Chief Executives
www.wales.nhs.uk The College of Podiatry
The Royal College of Radiologists
https://doi.org/10.1371/journal.pone.0214630.t003
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Data collection process and data items
Selected documents were entered into a Microsoft1 Excel for Mac (version 16) spreadsheet.
Home nation and professions covered by the reference were noted, and whether the reference
related to policy or consultation. The full texts were read, and notes made of any reference to
NMP, including the context.
Risk of bias assessment
Unlike research papers, whether qualitative or quantitative in nature, policy and consultation
documents are not developed according to well-recognised principles. Risk of bias assessment
is therefore not appropriate for this type of document and was not conducted. Policy docu-
ments are liable to be biased towards the ethos of the government in power at the time and
documents produced by profession specific bodies towards their profession. The results are
reported according to the relevant government era and, where appropriate, the specific profes-
sional body.
Data syntheses
Information from the selected documents underwent narrative synthesis with visual depic-
tions, described as an appropriate approach for non-research documents [24–26]. Following
tabulation and data extraction, the selected documents were grouped depending on whether
they concerned policy or consultation. To aid this process and to visualise the time distribution
they were also plotted on a timeline, with a further timeline developed for the consultation
documents. Using these techniques, a narrative summary was able to be developed by one
researcher (EGC), and the findings were then debated and critically assessed by all authors to
reach agreement.
One of the authors (EGC) is a practising pharmacist independent prescriber and NMP lead
for an acute trust. In this role they support other non-medical prescribers and have an interest
in NMP developments. This researcher standpoint is balanced by the other authors, who do
not have prescribing qualifications.
Results
Policy document selection and characteristics
The search strategy identified 99 full text articles to be assessed for inclusion. Following exclu-
sions, 45 documents were included in the review (Fig 1).
Of the included documents, 23 relate to policy or strategic report documents (see Table 4),
and 22 to the consultation process concerning extension of independent NMP responsibilities
to various healthcare professions (see Table 5).
The policy and strategic report documents relate to a single profession (nursing 3, phar-
macy 7), multiple professions (12), or generic NMP (one). The majority concern matters in
the home nations (England 12, Scotland 4, Wales 3 and Northern Ireland 1) with only 3 con-
cerning the United Kingdom. They can be divided into two chronological eras, with just over
half published between 2006 and 2010, and the remainder published since 2013 (Fig 2).
Synthesis of results
The Labour Government era 2006–2010. Four of the early documents comprised guid-
ance issued by the home nations to support NMP. These were released as the relevant regula-
tions governing prescribing were amended to permit independent NMP. The first was
released by the Department of Health in April 2006, coinciding with the initial changes in
Non-medical prescribing in the United Kingdom National Health Service: Policy review
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legislation and regulations permitting independent prescribing by nurses and pharmacists [15,
27, 28]. This was followed by Scotland’s guidance, released in July 2006, Northern Ireland’s
guidance in December 2006 and the Welsh guidance in 2007 [29–31]. All four documents are
similar in nature; however, Scotland’s relates to nurse prescribing only whereas the other three
relate to nurse and pharmacist prescribing. This reflects the changes made by the home nations
whereby England, Wales and Northern Ireland each introduced nurse and pharmacist inde-
pendent prescribing simultaneously, whereas Scotland introduced nurse independent pre-
scribing first, followed a year later by pharmacist independent prescribing. Although the bulk
of these documents relates to practical implementation guidance, each states the core policy
drivers behind NMP which were:
• improving patient care, without reducing safety
• making it easier to patients to access the medicines they require
• increasing patient choice
• utilising the skills of health professionals
• supporting team working
The Welsh guidance included the additional benefits of improving healthcare capacity and
enhancing patient access for advice and services.
Fig 1. PRISMA paper selection flow diagram.
https://doi.org/10.1371/journal.pone.0214630.g001
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Table 4. Policy and strategic report documents.
Title Source Date Home
Nation
Professional Group Brief overview
of contentsNurse Pharmacist Physiotherapist Podiatrist Paramedic Radiographer Optometrist AHP NMP
Improving
Patients’ Access
to Medicines: A
Guide to
Implementing
Nurse and
Pharmacist
Independent
Prescribing
within the NHS
in England
Department of
Health
Apr-
06
England Y Y Highlights aims
of independent
prescribing
Describes the
scope of
everything
needed to
implement
independent
prescribing
Medicines
Matters. A guide
to mechanisms
for the
prescribing,
supply and
administration
of medicines
Department of
Health
Jul-
06
United
Kingdom
Y Y Y Describes the
prescribing,
supply and
administration
of medicines,
Including the
aims of the non-
medical
prescribing
program
Guidance for
Nurse
Independent
Prescribers and
for Community
Practitioner
Nurse
Prescribers in
Scotland: A
Guide for
Implementation
Scottish
Executive
Health
Department
Aug-
06
Scotland Y Highlights aims
of independent
prescribing
Describes the
scope of
everything
needed to
implement
independent
prescribing
Improving
Patients’ Access
to Medicines: A
Guide to
Implementing
Nurse and
Pharmacist
Independent
Prescribing
within the HPSS
in Northern
Ireland
Department of
Health Social
Services and
Public Safety
Dec-
06
Northern
Ireland
Y Y Highlights aims
of independent
prescribing
Describes the
scope of
everything
needed to
implement
independent
prescribing
The best
medicine: the
management of
medicines in
acute and
specialist trusts
Commission
for Healthcare
Audit and
Inspection
Jan-
07
England Y Y Covers all
aspects of
medicines
management in
secondary care
Includes a brief
mention of non-
medical
prescribing
Mental Health:
New Ways of
Working for
Everyone.
Progress Report
Department of
Health,
National
Institute for
Mental Health
in England
National
Workforce
Programme
Apr-
07
England Y Covers progress
with developing
New Ways of
Working, and
plans and
strategies for
further
development.
Described how
non-medical
prescribing will
support these
changes in
practice
(Continued)
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Table 4. (Continued)
Title Source Date Home
Nation
Professional Group Brief overview
of contentsNurse Pharmacist Physiotherapist Podiatrist Paramedic Radiographer Optometrist AHP NMP
Non medical
prescribing in
Wales—A guide
for
implementation
Welsh
Assembly
Government
Jul-
07
Wales Y Y Highlights aims
of independent
prescribing
Describes the
scope of
everything
needed to
implement
independent
prescribing
New Ways of
Working for
Everyone: A best
practice
implementation
guide
Department of
Health,
National
Institute for
Mental Health
in England
National
Workforce
Programme
Oct-
07
England Y Provides
guidance on
implementing
New Ways of
Working, using
theoretical
examples to
illustrate points
Examples
include the use
of non-medical
prescribing
Consultation on
A Safe
Prescription:
Developing
Nurse, Midwife
and Allied
Health
Profession
(NMAHP)
Prescribing in
NHS Scotland
The Scottish
Government,
Primary Care
Division
Nov-
07
Scotland Y Y Consultation
strategy paper
covering
implementation
of non-medical
prescribing and
the role of non-
medical
prescribing in
service
development
and redesign
Pharmacy in
England:
Building on
strengths–
delivering the
future (Cm
7341)
Department of
Health
Apr-
08
England Y Government
White Paper
describing the
current role of
pharmacy and
how pharmacy
skills could be
better utilised
Includes use of
prescribing by
pharmacists
with case studies
as examples
Allied health
professions
prescribing and
medicines
supply
mechanisms
scoping project
report
Department of
Health
Jul-
09
England Y Y Y Describes
current position
with regard to
AHPs and their
changing role
Highlights that
expansion of
prescribing
rights would
improve patient
care, with
examples
Identifies
priorities in
prescribing
expansion
(Continued)
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Table 4. (Continued)
Title Source Date Home
Nation
Professional Group Brief overview
of contentsNurse Pharmacist Physiotherapist Podiatrist Paramedic Radiographer Optometrist AHP NMP
A safe
prescription;
Developing
nurse, midwife
and allied health
profession
(NMAHP)
prescribing in
NHS Scotland
The Scottish
Government
Sep-
09
Scotland Y Y Final version of
the consultation
strategy paper
Includes key
healthcare
policy drivers
where non-
medical
prescribing may
be beneficial
Pharmacist
Prescriber
Training
Working Group
Report for the
MPC
Programme
Board
Medical
Education
England
Jan-
10
England Y Describes the
background to
the pharmacist
prescribing,
current context
and future
developments
Highlights
changes to
undergraduate
teaching that
should occur to
optimise
pharmacist as
prescribers
Prescription for
Excellence
The Scottish
Government
Sep-
13
Scotland Y Describes the
Scottish vision
that all
pharmacists will
become
independent
prescribers,
working in
partnership with
medical
practitioners
Now or never:
shaping
pharmacy for
the future
The Royal
Pharmaceutical
Society
Nov-
13
England Y Covers the
current
pharmacy
activity and
potential future
developments.
Include
examples of
pharmacist
prescribers and
mentions how
many have
qualified.
Highlights poor
awareness of
pharmacy
profession by
patients and
wider healthcare
service
Seven Day
Services in
Hospital
Pharmacy:
Giving patients
the care they
deserve
The Royal
Pharmaceutical
Society
Jun-
14
United
Kingdom
Y Describe the
challenges in
moving to full
seven-day
services
Gives examples
of pharmacist
prescribers
supporting
seven-day
services
(Continued)
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Table 4. (Continued)
Title Source Date Home
Nation
Professional Group Brief overview
of contentsNurse Pharmacist Physiotherapist Podiatrist Paramedic Radiographer Optometrist AHP NMP
Our Plan for
Primary Care in
Wales up to
March 2018
Welsh
Assembly, NHS
Wales
Nov-
14
Wales Y Y Y Highlights
general practice
doctors’
workforce
shortfall
Highlights how
healthcare
professionals
can support
general
practitioners,
including non-
medical
prescribing
A Planned
Primary Care
Workforce for
Wales:
Approach and
development
actions to be
taken in support
of the plan for a
primary care
service in Wales
up to 2018
Welsh
Assembly, NHS
Wales
Jun-
15
Wales Y Y Y Y Covers
workforce
development,
profession by
profession, to
enable support
for general
practitioners
Highlights the
need for
expansion in
non-medical
prescribers
The future of
primary care:
Creating teams
for tomorrow
Health
Education
England
Jul-
15
United
Kingdom
Y Y Y Describes the
challenges in
general practice
Highlights
development of
non-medical
professionals to
support general
practice
Transformation
of seven day
clinical
pharmacy
services in acute
hospitals
NHS England Sep-
16
England Y Describes the
actions needed
to develop seven
day working
Includes
examples of
pharmacist
prescribing
supporting the
multi
professional
team
Improving care
for people with
Long Term
Conditions
The Royal
Pharmaceutical
Society
Nov-
16
England Y Describes
improving care
of patients with
long term
conditions,
utilising
pharmacists’
skills
Recommends
prescribing as a
key skill
(Continued)
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Scotland conducted a prescribing strategy consultation exercise, with the final strategy
launched in 2009 [32, 33]. These documents covered independent prescribing by nurses and
midwives and supplementary prescribing by allied health professionals but not pharmacist
prescribers. They highlighted the variable adoption of NMP across Scotland and had the aim
of improving uptake of NMP to support the NHS boards in delivering patient centred care.
There were two remaining prescribing specific documents in this era; the scoping report on
Allied Health Professional (AHP) prescribing and a report on pharmacist prescribing training
[34, 35]. The former reviewed the developing role of AHPs (see Table 2) and highlighted some
of the limitations resulting from their inability to prescribe; identifying which professions
would benefit most from the ability to prescribe, either independently or as a supplementary
prescriber, and also which professions should not become prescribers. Additionally, the pro-
fessions were prioritised, with physiotherapy and podiatry identified as high priorities for
independent prescribing, followed by radiography. The latter document reviewed pharmacist
prescribing experiences and recommended several changes to training, both at undergraduate
level and regarding the prescribing course.
The remaining documents produced in this era, although generic in nature, include refer-
ences to NMP. The first was a Department of Health document released in 2006 providing fur-
ther guidance on medicine supply and reiterating the drive behind NMP [36]. The document
included several proposed next stages for NMP:
• To consult on optometrist independent prescribing
• To promote nurse and pharmacist independent prescribing
• To review the prescribing needs of emerging roles
Table 4. (Continued)
Title Source Date Home
Nation
Professional Group Brief overview
of contentsNurse Pharmacist Physiotherapist Podiatrist Paramedic Radiographer Optometrist AHP NMP
The General
Practice Nursing
Workforce
Development
Plan
Health
Education
England
Mar-
17
England Y Review of
general practice
nursing,
highlighting
practice role and
potential
workforce issues
Identifies
challenge of
freeing time for
prescribing
training
Facing the Facts,
Shaping the
Future: A draft
health and care
workforce
strategy for
England to 2027
Public Health
England
Dec-
17
England Y Y Describes the
current
workforce issues
including
recruitment and
retention
Reviews this in
context of
services and of
individual staff
groups
AHP–allied health professional, NMP–Non-medical prescriber
https://doi.org/10.1371/journal.pone.0214630.t004
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Table 5. Consultation documents.
Title Source Date Home
Nation
Professional Group Brief overview of
contentsNurse Pharmacist Physiotherapist Podiatrist Paramedic Radiographer Optometrist
Consultation on
proposals to introduce
independent
prescribing by
optometrists (MLX
334)
Medicines &
Healthcare
Products
Regulatory
Agency
Aug-
06
United
Kingdom
Y Describes scenarios
where optometrist
prescribing would be
beneficial
Includes options for
immediate referral and
management of long-
term conditions
Public consultation—
independent
prescribing of
controlled drugs by
nurse and pharmacist
independent
prescribers (MLX338)
Home Office,
Drug Strategy
Unit
Mar-
07
United
Kingdom
Y Y Includes risk and impact
assessments
Highlights that
controlled drug
prescribing would
support the aims of
improving patient care
and choice
Public consultation
(MLX 334): Proposals
to introduce
independent
prescribing by
optometrists—outcome
Medicines &
Healthcare
Products
Regulatory
Agency
Aug-
08
United
Kingdom
Y Report of outcome of
public consultation,
including confirmation
that CHM recommend
optometrist prescribing
Proposals to introduce
prescribing
responsibilities for
paramedics:
stakeholder
engagement
Department of
Health
Mar-
10
United
Kingdom
Y Highlights scenarios
where prescribing would
be beneficial
Discusses which
paramedics would be
suitable, and planned
safeguards
Engagement exercise:
To seek views on
possibilities for
introducing
independent
prescribing
responsibilities for
podiatrists
Department of
Health
Sep-
10
United
Kingdom
Y Described, with
examples, podiatry roles
and training
Describes potential
benefits of independent
prescribing
Uses open questions to
gain information from
stakeholders
Engagement exercise:
To seek views on
possibilities for
introducing
independent
prescribing
responsibilities for
physiotherapists
Department of
Health
Sep-
10
United
Kingdom
Y Described, with
examples, physiotherapy
roles and training
Describes potential
benefits of independent
prescribing
Uses open questions to
gain information from
stakeholders
Proposals to introduce
independent
prescribing by
podiatrists: impact
assessment
Department of
Health
Jul-
11
United
Kingdom
Y Describes potential
financial and other
benefits from
streamlined pathways for
each option under
consideration
Consultation on
proposals to introduce
independent
prescribing by
podiatrists
Department of
Health
Sep-
11
United
Kingdom
Y Public consultation
describing current role of
podiatrists and scenarios
where prescribing would
be beneficial
Seeks clarification on
areas such as education
and governance
Prescribing unlicensed
medication excluded
following engagement
exercise
(Continued)
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Table 5. (Continued)
Title Source Date Home
Nation
Professional Group Brief overview of
contentsNurse Pharmacist Physiotherapist Podiatrist Paramedic Radiographer Optometrist
Consultation on
proposals to introduce
independent
prescribing by
physiotherapists
Department of
Health
Sep-
11
United
Kingdom
Y Public consultation
describing current role of
physiotherapists and
scenarios where
prescribing would be
beneficial
Seeks clarification on
areas such as education
and governance
Prescribing unlicensed
medication excluded
following engagement
exercise
Summary of the
Commission on
Human Medicines
meeting held on
Thursday 17th &
Friday 18th May 2012
Commission
on Human
Medicines
May-
12
United
Kingdom
Y Y Reports that the
committee was able to
support independent
prescribing for
podiatrists and
physiotherapists in line
with results from
consultation exercise
Summary of Public
Consultation on
Proposals to Introduce
Independent
Prescribing by
Physiotherapists
Department of
Health
Jul-
12
United
Kingdom
Y Majority of respondents
supported independent
prescribing from a full
formulary
There was also support
for a limited list of
controlled drugs and to
allow mixing of
medicines
Proposals to introduce
independent
prescribing by
physiotherapists:
impact assessment
Department of
Health
Jul-
12
United
Kingdom
Y Describes potential
financial and other
benefits from
streamlined pathways for
each option under
consideration
Includes risk and
governance
Summary of Public
Consultation on
Proposals to Introduce
Independent
Prescribing by
Podiatrists
Department of
Health
Jul-
12
United
Kingdom
Y Majority of respondents
supported independent
prescribing from a full
formulary
There was also support
for a limited list of
controlled drugs and to
allow mixing of medicine
Independent
prescribing by
radiographers: Impact
Assessment
NHS England Jan-
15
United
Kingdom
Y Set out a policy
background and
describes scenarios where
prescribing may be
beneficial e.g. managing
radiotherapy side effects
Describes financial costs,
governance
arrangements and
potential risks
Consultation on
proposals to introduce
independent
prescribing by
radiographers across
the United Kingdom
NHS England Feb-
15
United
Kingdom
Y Public consultation
Describes current role
and scenarios where
prescribing may be
beneficial
Describes governance
proposals
(Continued)
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Table 5. (Continued)
Title Source Date Home
Nation
Professional Group Brief overview of
contentsNurse Pharmacist Physiotherapist Podiatrist Paramedic Radiographer Optometrist
Consultation on
proposals to introduce
independent
prescribing by
paramedics across the
United Kingdom
NHS England Feb-
15
United
Kingdom
Y Public consultation
Describes paramedic
roles and changes in
practice that result in
more patients being
treated at home
Highlights that this
would be for advanced
paramedics
Proposal to introduce
independent
prescribing by
paramedics: impact
assessment
NHS England Feb-
15
United
Kingdom
Y Highlights current issues
and rationale for
prescribing
Details of the various
options and associated
costs
Identifies potential risks
Commission on
Human Medicines and
Expert Advisory Group
Final Summary
Minutes
Commission
on Human
Medicines
Oct-
15
United
Kingdom
Y Y Describes that committee
was unable to support
paramedic or diagnostic
radiographer
independent prescribing
The Committee was able
to support the
therapeutic radiographer
independent prescribing
Independent
prescribing by
therapeutic
radiographers
NHS England Jan-
16
United
Kingdom
Y Impact assessment for
therapeutic
radiographers only
Set out policy
background and
describes scenarios where
prescribing may be
beneficial
Describes financial costs,
governance
arrangements and
potential risks
Summary of the
responses to the public
consultation on
proposals to introduce
independent
prescribing by
paramedics across the
United Kingdom
NHS England Feb-
16
United
Kingdom
Y Majority of respondents
supported independent
prescribing by
paramedics
There was also support
for a limited list of
controlled drugs and to
allow mixing of medicine
Summary of the
responses to the public
consultation on
proposals to introduce
independent
prescribing by
radiographers across
the United Kingdom
NHS England Feb-
16
United
Kingdom
Y Majority of respondents
supported independent
prescribing from a full
formulary
There was also support
for a limited list of
controlled drugs and to
allow mixing of
medicines
It was noted that the
CHM supported
independent prescribing
for therapeutic
radiographers only
(Continued)
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This was followed by the Audit Commission report in 2007 on medicines management,
which mentioned the development of nurse and pharmacist prescribing and described the dis-
tribution of prescribers at that time [37]. Data collection had been in 2005 and 2006 and there-
fore the majority of these data would have been collected from supplementary prescribers.
They recommended that trusts identify where NMP would provide the maximum benefit clin-
ically and that work should be performed to identify why some non-medical prescribers did
not prescribe regularly.
The “New Ways of Working in Mental Health” project released two documents in 2007, a
progress report and an implementation guide [38, 39]. The progress report reiterated the five
core drivers behind NMP and described how NMP should be incorporated into the changes in
working practice such as multidisciplinary team working. The implementation guide provided
theoretical examples of changed practice which incorporated NMP.
The final document in this era was the pharmacy White Paper [40]. This highlighted the
roles that pharmacists could play in improving the healthcare of patients, including the exam-
ple of prescribing in long-term conditions. Although some case studies were described, most
of the suggested roles for prescribers were aspirational.
The Coalition and Conservative Governments era 2013–2017. The first two documents
in this era both concerned the role of pharmacy in providing patient centred health care. The
first of these was the Scottish Government’s vision for pharmacy which envisaged integration
of pharmacists into all aspects of healthcare [41]. Central to this vision was the aim of having
all pharmacists qualified as independent prescribers. The second document was a report by
the Royal Pharmaceutical Society on pharmacy activity and future potential [42]. Various
examples of prescribing practice are described (for example, pharmacists running cardiovascu-
lar and chronic pain clinics) but the comment is made that it is not sufficient simply to provide
prescribing courses, that roles must also be developed that utilise this activity. The report con-
trasts the English and Scottish governments approach to pharmacy, to the detriment of the
English government’s approach.
There are three further pharmacy specific documents in this era, with two of these concern-
ing seven-day hospital clinical pharmacy services. The first was a report by the Royal Pharma-
ceutical Society discussing potential approaches to providing a seven-day service and the
associated challenges [43]. Examples where seven-day pharmacy services had been imple-
mented were given, with many of the contributors anticipating the use of pharmacist prescrib-
ers to support delivery. The second report, from NHS England, describes the need to deliver
clinical pharmacy services seven days a week, highlighting the impact that pharmacy services
make and describing the importance of prescribing to support the multi-professional team
Table 5. (Continued)
Title Source Date Home
Nation
Professional Group Brief overview of
contentsNurse Pharmacist Physiotherapist Podiatrist Paramedic Radiographer Optometrist
Summary of the
Commission on
Human Medicines
meeting held on
Thursday 7th
September 2017
Commission
on Human
Medicines
Sep-
17
United
Kingdom
Y Brief notes that feedback
on independent
prescribing by
paramedics had been
considered and
discussed, and that they
would now endorse the
recommendation to
support prescribing
CHM—Commission on Human Medicines
https://doi.org/10.1371/journal.pone.0214630.t005
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[44]. The final pharmacy specific document was the Royal Pharmaceutical Society produced
policy, concerning care for patients with long-term conditions [45]. This highlights the role
that pharmacists can play in supporting these patients, and makes a number of key recommen-
dations, the first of which is that pharmacists should have the opportunity to become prescrib-
ers enabling them to manage treatment of these patients.
The Welsh Assembly produced a plan for primary care in 2014, followed by a primary care
workforce development plan in 2015 [46, 47]. The first of these documents highlighted the
increasing pressure on general practice from a combination of increasing demand, a shortage
of general practitioners and financial constraints. The focus was on health rather than ill-
health and to provide person centred care within the local community, using the most appro-
priate healthcare professional for the task. Advanced practice such as NMP was seen to relieve
pressure on general practitioners. The associated workforce plan described the potential role
of NMP for various professions and provided examples. One such example is the monitoring
of low risk glaucoma patients by optometrists, and the document comments that there will be
an increased need for optometrists to train as prescribers as they develop these advanced roles.
A report commissioned by Health Education England on primary care, published in 2015,
described how primary care could be delivered using a wide range of healthcare professionals
[48]. Included in the recommendations was the role of the prescribing pharmacist to support
medicines optimisation activities, such as changing the medication of patients at risk of poly-
pharmacy and adverse drug events, and the potential for physiotherapist prescribers to enable
them to provide streamlined care for patients [48]. This was followed in 2017 by the general
practice nursing workforce plan [49]. Prescribing is described as complementing the nursing
role, but challenges are acknowledged particularly in enabling time for training. Finally in this
era, there was the draft workforce strategy for England which was released for consultation in
December 2017 [50]. This specifically mentioned prescribing in the pharmacy section, describ-
ing a project to put advanced pharmacists with prescribing qualifications into emergency
departments, and also commented that increased numbers of nurse prescribers would be
required in the community and primary-care sectors. No mention was made of prescribing by
any other non-medical healthcare professional.
Consultation documents. Two public consultations, to gauge opinion, were launched
during the period 2006–2008; the first concerned the introduction of independent prescribing
for optometrists, and the second regarding controlled drug prescribing by nurse and pharma-
cist independent prescribers. The consultation process for the introduction of independent
prescribing by optometrists was launched in August 2006, with the outcome announced in
2008, and associated legislation passed the same year [51–53]. This time period contrasts with
the second consultation in 2007 on controlled drug prescribing, where agreement that this
should be permitted was reached, but changes in legislation were not enacted until 2012 [54–
56].
Following the 2009 AHP scoping report, stakeholder engagement exercises were launched
in 2010 to investigate independent prescribing rights for both podiatry and physiotherapy, fol-
lowed by consultation exercises in 2011 and the outcome and approval in 2012, the whole pro-
cess taking a little under two years [57–65]. The consultation for radiographers was launched
in 2015 with approval for therapeutic radiographers only granted in 2016 (diagnostic radiogra-
phers were excluded) [66–70]. These relatively short consultation exercises contrast strongly
with that of the paramedics. The initial document mentioning paramedic prescribing had
Fig 2. Timeline of selected documents. Policy–black, Optometrist–brown, Radiographer–purple, Nurse/Pharmacist–
yellow, Paramedic–blue, Podiatrist–red, Physiotherapist- green.
https://doi.org/10.1371/journal.pone.0214630.g002
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been published in 2005 [71], with the stakeholder engagement exercise held in 2010, a year
before that of the podiatrists and physiotherapists [57, 61, 72]. The potential for paramedic
prescribing was reiterated in the 2013 urgent care report, which described the changing role of
paramedics, and the potential for further role extension such as treatment at home by a para-
medic to reduce demand on emergency care services [73]. Furthermore, when the formal para-
medic consultation process began, advanced paramedics had started to work in a range of
settings such as emergency care departments as well as the more traditional ambulance service
(see Table 2) [74]. The paramedic and radiographer consultation exercises ran simultaneously,
but final approval for paramedics was only granted in 2017 [74–78]. A comment is made in
the related paramedic impact assessment that the consultation exercise was delayed because of
capacity issues [75]. The relative timescales are visually depicted in Fig 3.
Discussion
Summary of evidence
This is the first such policy review bringing together the UK policy documents concerning
NMP to describe the role of this evolving activity. The document review reveals two main
themes, which are expanded on below. The first theme highlights issues arising from inspect-
ing the chronological aspects of the selected documents. The second theme covers the evolving
approach to healthcare provision and describes how NMP has become embedded into routine
practice for many non-medical prescribers. However, differences in practice remain and these
are highlighted.
Chronological aspects. Inspection of the timeline of included documents reveals a notice-
able gap between 2010 and 2013, when no reports or strategic documents concerning NMP
were released by a government body. The beginning of this period coincides with the change
in government in 2010 from Labour to the Coalition. Two factors are likely to be responsible
for this dearth of publications. Firstly, the Coalition embarked on an overall reorganisation of
the NHS in England, initiated in the 2010 White Paper ‘Equity and Excellence’, and enacted
through the Health and Social Care Act in 2012 [79, 80]; focussing on the high level structure
rather than finer detail. Secondly, the country had been in economic recession since 2008 and
the Coalition’s 2010 budget introduced austerity measures designed to reduce the nation’s
budget deficit and improve economic growth [81, 82]. The government attempted to protect
the NHS from financial cuts implemented more generally across all services, however the
funding growth rate for the NHS in England was curtailed to 1.4% a year compared with 6% a
year under the previous Labour government [83]. Government priorities were therefore con-
cerned with major reform of the NHS structure and introduction of commissioning groups,
rather than the continued development of existing practices.
The change in government also probably explains the delay in extending controlled drug
prescribing for nurses and pharmacist independent prescribers. Extending controlled drug
prescribing rights requires the agreement of the Department of Health, the Home Office, the
Medicines and Healthcare Products Regulatory Agency and the Advisory Council on the Mis-
use of Drugs (ACMD), and, subsequently, amendments to the Misuse of Drugs Regulations
2001 and medicines legislation [54]. The consultation closed in June 2007, and in November
2007 the ACMD wrote to the Under-Secretary of State at the Home Office, and the Minister of
State for Public Health at the Department of Health, to support the proposals and the change
in legislation [84]. However, the required change in legislation was only enacted in 2012, and
it can be surmised that with the Coalition’s priorities focused on reorganisation of the whole
NHS, extending controlled drug prescribing to nurse and pharmacist independent prescribers
was accorded low priority [55, 56].
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The consultation processes for the AHPs (physiotherapists, podiatrists and radiographers)
were all concluded within a reasonable timeframe, despite the change in government occur-
ring between publication of the AHP scoping report and initiation of the physiotherapy and
podiatry consultation exercises [34, 57, 61]. The AHP scoping report had demonstrated a clear
role for prescribing for each of these professions in streamlining and improving patient care.
In addition, the report prioritised which professions should be considered first, taking into
consideration the strength of case for prescribing for each profession and the capacity of the
Department of Health, and Medicines and Healthcare Products Regulatory Agency to conduct
the necessary consultations. As an aside, the consultation exercises reflect the NHS reorganisa-
tion, with the physiotherapy and podiatry consultation exercises conducted under the auspices
of the Department of Health, and subsequent consultation exercises under NHS England.
In comparison, the lack of clarity concerning how prescribing would be utilised by para-
medics, and their evolving role, explains the extended time period between the initial recom-
mendation regarding paramedic independent prescribing and final approval. At the time of
the initial report paramedics had recently become registered with the Health Care Professions
Council, and the NHS advanced practice role was developing [71] with a shift in training from
resuscitation, to assessing and treating the patient at home. The urgent care report in 2013
highlighted the potential for treatment by paramedics to reduce demand on emergency care
services [73]. Following the consultation, the Commission on Human Medicines (CHM) was
unable to recommend prescribing by paramedics because of concern that paramedics would
need training in a large range of conditions to ensure patient safety [66]. The minutes for the
2017 CHM meeting simply say that they endorse the recommendations for independent pre-
scribing for paramedics, and it is to be presumed that they had been provided with reassurance
concerning the training and role of paramedics [78].
Healthcare provision—evolution of policy. The five drivers for prescribing documented
in the implementation guidance reiterated the aims of the 2000 NHS White Paper to improve
patient care and break down the traditional demarcations between professions [6, 27, 29–31].
These and other early documents such as Medicines Matters, and the “Mental Health New
Ways of Working” project were published before full independent prescribing was embedded
[36, 38, 39]. As such, they discuss the potential for NMP to improve patient care and, in partic-
ular with the mental health documents, develop novel ways of working. Medicines Matters
explicitly commented that NMP was unsuitable for patients with complex conditions, recom-
mending the use of supplementary prescribing instead [36]. The pharmacy White Paper listed
prescribing as one of the activities that pharmacists could undertake, including in the care of
long-term conditions, but many of the examples are theoretical [40]. The 2009 AHP scoping
report highlights the changing role of, for example physiotherapists or podiatrists, comment-
ing that they may now be responsible for a full package of patient care but were hampered by
the inability to prescribe independently [34]. Again, this document describes potential or theo-
retical benefits.
However, when the Scottish government published their NMP strategy, they were able to
draw on a number of published papers providing evidence of the benefits [33], although in
reality the only full independent prescribers included were nurses. Likewise the pharmacist
prescriber training report in 2010 was also able to draw on practice examples to illustrate vari-
ous different ways that independent prescribing had been implemented [35].
The 2010 White Paper ‘Equity and excellence: liberating the NHS’ signalled a change in
direction for the health service, putting the patient at the centre of care with ‘no decision about
me without me’ [79] but without the previous emphasis on workforce development; a point
highlighted in a later staffing report [85]. The need for responsive and patient centred care,
within the constraints of limited finances, was further developed in the subsequent Five-Year
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Forward View [19]. This document sets the need to provide more integrated care, giving
patients greater control, against the background of increasing demand, rising costs resulting
from new technologies, and budgetary constraints. Although prescribing is not specifically
mentioned, there is a call to challenge traditional ways of working and to use the most appro-
priate healthcare professional for the task in hand.
This approach is echoed by the Welsh Assembly primary care plan, which describes a future
model of primary-care in which the general practitioner acts as the leader over a multi profes-
sional team, who between them care for the patient [46]. The Welsh Assembly associated
workforce development plan depends on other healthcare professionals taking on roles tradi-
tionally associated with general practitioners or secondary care, with NMP perceived as inte-
gral to these developments [47]. The English primary care report [48] describes a number of
Fig 3. Consultation timeline.
https://doi.org/10.1371/journal.pone.0214630.g003
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approaches to reducing the burden on general practitioners. Included in this are new models
of practice such as the work of physicians’ associates (see Table 2), but as The Health Founda-
tion comments, their role in relieving pressure on doctors will be limited if they cannot pre-
scribe [85]. Nurse prescribing is not specifically mentioned, although the report does identify
that nurses have many responsibilities, including the care of patients with long-term condi-
tions. More recently, the draft workforce strategy describes advanced practice for a number of
professions such as nursing and paramedics but does not define what this entails [50]. It also
describes podiatry and physiotherapy being potential first contact points for patients with
musculoskeletal disorders. Prescribing would support all of these activities but is not explicitly
mentioned and it could be perceived that NMP is seen to be so routine and embedded in prac-
tice for these professions that it warrants no mention. This compares with the pharmacy situa-
tion, where the same document put pharmacist independent prescribing as one of the priority
areas to address. Other reports also make explicit mention of pharmacy prescribing as one of
the tools to enhance medicines optimisation practices [44, 45] suggesting that pharmacist pre-
scribing is still not embedded into routine practice.
A review of the professional distribution of policy documents supports this supposition
concerning NMP becoming routine practice, with the majority involving generic NMP or cov-
ering multiple NMP professions (see Table 4). Of the three nursing specific policy documents,
two date from before 2010, and the final one from 2017 [29, 38, 49]. Pharmacy alone of the
professions is associated with multiple policy documents since 2013; with three by the Royal
Pharmaceutical Society and one by each of the Scottish government and NHS England [41–
45]. Similar recent policy documents were unable to be identified for any other of the NMP
professions, despite in-depth searching. This may reflect the need for pharmacists to develop
new roles and skills as the traditional dispensing role diminishes as a consequence of techno-
logical advances such as electronic prescribing and robotic dispensing. With medicines central
to pharmacy practice, it is appropriate that these roles support medicines optimisation; how-
ever, these are not existing roles that a pharmacist can move into, rather they are roles that
require creating. It is also notable that while community (drugstore) pharmacists comprise the
majority of the profession, most prescribers are found in primary and secondary care instead,
indicating challenges with adopting prescribing in community practice [86, 87]. The pharmacy
orientated policy documents describe to both pharmacists and commissioners how pharmacist
prescribing could work in practice. This compares with other healthcare professions, such as
physiotherapy, where medicines form an adjunct to their main practice area, enhancing role
expansion. Pharmacy could also be perceived to be an innately cautious profession [88], and
the policy documents could thus serve to overcome a reluctance to adopt innovative working
practices.
It is notable that there has been a shift regarding the role that NMP plays in the care of
patients. The 2006 document, Medicines Matters, envisaged independent prescribers utilising
a comparatively small personal formulary of drugs, excluding controlled drugs and unlicensed
medicines, to treat uncomplicated conditions [36]. Since independent prescribing for nurses
and pharmacists was launched, their prescribing rights have been gradually extended to
include unlicensed medicines and controlled drugs [54, 89] and more recent documents
describe the role NMP has in the care of long-term conditions and complex patients, such as
palliative care [45, 48]. This is echoed by the changing role of medical staff in patient care. The
early implementation guidance described medical staff retaining an overview of patient care,
with nurse and pharmacist prescribing intended to improve patients’ access to medicines [27,
29–31]. Subsequent consultation processes (podiatry, physiotherapy, radiography and para-
medics) have seen a change so that the examples given in these documents describe the provi-
sion of a complete package of care without the need to involve other healthcare professionals.
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Indeed, the consequent reduction in costs through reducing appointments is listed as a benefit
in the impact assessments [60, 62, 68, 75]. More recently, the Health Education England pri-
mary care report envisages that general practitioners will be treating patients with complex
conditions, with other healthcare professionals providing routine care [48].
Strengths and limitations
The strengths of the present policy review include the systematic, iterative approach to identi-
fying relevant policy documents, using document mapping techniques to identify missing doc-
uments. The dynamic nature of this healthcare area inevitably means that this review provides
a snapshot of the situation between 2006 and 2018, which may well be superseded, for example
if political changes resulting from unanticipated developments such as ‘snap’ general elections
and referenda occur. The selected documents relate to the UK and the home nations only and
this may limit generalisability to other countries. Additionally, although the legislation permits
the use of NMP in UK private healthcare, the policy documents concern the use of NMP in the
NHS and this may further limit generalisability for alternative healthcare systems. However, it
can also be argued that the development in the UK could provide a roadmap for other coun-
tries wishing to expand their non-medical prescribing workforce, by providing examples of
successful NMP implementation into routine practice.
Despite extensive searches there may well be further policy documents available, such as
from the home nations or professional bodies that are not identifiable through a search
strategy.
Conclusions
In conclusion it can be seen that this policy review has revealed that the government approach
to NMP has changed over the 12-year period from 2006. NMP was originally intended as a
means of improving patient choice and access to medicines, whilst also developing the work-
force. A subsequent change in government (and associated political ideology) combined with
financial and staffing shortfalls have resulted in the emphasis subtly changing to NMP sup-
porting, or even replacing, medical practitioners. Patients are expected to be cared for, and
treated by, the most appropriate health care professional such as a physiotherapist for a muscu-
loskeletal problem. Medical workload is thus reduced, enabling the more complex cases to still
be treated by medical practitioners despite a reduction in their numbers. Costs are reduced by
streamlining care through reducing multiple appointments with different healthcare profes-
sionals, and by using the most appropriately qualified professional.
This policy review has also highlighted the role that NMP now plays in patient care, with
prescribing perceived as one activity in the advanced practice armamentarium used to treat
and support patients, enabling patients to benefit from receiving a complete package of care
from a single healthcare professional. As prescribing has become embedded into day to day
practice for the majority of the NMP professions, so the need to highlight prescribing in policy
documents has diminished (as seen in the recent workforce development document), just as it
is no longer felt necessary to describe in detail advanced practice in these professions. As new
models of practice are developed, such as use of physician’s associates, so the demand for
NMP to expand to other healthcare professional groups continues, with the implication that
prescribing is integral to these roles.
However, this policy review has found that while NMP has become embedded into routine
practice for many professions, this is not universal. Despite pharmacists having achieved inde-
pendent prescribing rights in 2006, it would appear from the repeated policy documents
describing the need for pharmacist prescribers that it is still not embedded into pharmacists’
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routine practice. Medicines remain at the core of pharmacy practice through supply and opti-
misation but, until the new roles become established, prescribing has yet to be perceived as a
‘normal’ pharmacist activity.
This policy review has also highlighted the practical impact that a change in government
can have, as shown by the gap in policy document publication during the Coalition’s review
and reorganisation of the NHS, and the delays in legislation concerning controlled drugs.
However, these delays are not inevitable, as shown by the physiotherapist and podiatrist con-
sultations which were conducted during this period.
While these findings concern a publicly funded health service in a single country, and may
therefore be considered to have limited generalisability, there are messages that may resonate
in other settings. These concern the impact of reorganisation on service development and how
uptake of a novel activity is adopted by professions.
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